The expression of galectin-3 in breast cancer and its association with chemoresistance: a systematic review of the literature

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Characterization ofLGALS3(galectin-3) as a player in DNA damage response

(2014) Renato S Carvalho et al.   CANCER BIOLOGY & THERAPY

Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer

(2014) Hao Zhang et al.   PLoS One

Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia

(2013) Francesco Lo-Coco et al.   NEW ENGLAND JOURNAL OF MEDICINE

The DNA damage response and cancer therapy

(2012) Christopher J. Lord et al.   NATURE

A galectin-3 sequence polymorphism confers TRAIL sensitivity to human breast cancer cells

(2011) Nachman Mazurek et al.   CANCER

Galectin-3 germline variant at position 191 enhances nuclear accumulation and activation of β-catenin in gastric cancer

(2011) Seok-Jun Kim et al.   CLINICAL & EXPERIMENTAL METASTASIS

Importance of DNA damage checkpoints in the pathogenesis of human cancers

(2010) Angela Poehlmann et al.   PATHOLOGY RESEARCH AND PRACTICE

Clinicopathlogic and Immunohistochemical Characteristics of Triple Negative Invasive Lobular Carcinoma

(2010) Ja Seung Koo et al.   YONSEI MEDICAL JOURNAL

Calpain activation through galectin-3 inhibition sensitizes prostate cancer cells to cisplatin treatment

(2010) Y Wang et al.   Cell Death & Disease

Silencing of galectin-3 changes the gene expression and augments the sensitivity of gastric cancer cells to chemotherapeutic agents

(2009) Teak-Chin Cheong et al.   CANCER SCIENCE

Racial Disparity in Breast Cancer and Functional Germ Line Mutation in Galectin-3 (rs4644): A Pilot Study

(2008) V. Balan et al.   CANCER RESEARCH

Galectin-3 Expression in Tumor Progression and Metastasis of Papillary Thyroid Carcinoma

(2008) Hüseyin K. Türköz et al.   ENDOCRINE PATHOLOGY